| Literature DB >> 25237102 |
Iman Fares1, Jalila Chagraoui1, Yves Gareau2, Stéphane Gingras2, Réjean Ruel2, Nadine Mayotte1, Elizabeth Csaszar3, David J H F Knapp4, Paul Miller4, Mor Ngom4, Suzan Imren4, Denis-Claude Roy5, Kori L Watts6, Hans-Peter Kiem7, Robert Herrington8, Norman N Iscove9, R Keith Humphries4, Connie J Eaves4, Sandra Cohen5, Anne Marinier2, Peter W Zandstra3, Guy Sauvageau10.
Abstract
The small number of hematopoietic stem and progenitor cells in cord blood units limits their widespread use in human transplant protocols. We identified a family of chemically related small molecules that stimulates the expansion ex vivo of human cord blood cells capable of reconstituting human hematopoiesis for at least 6 months in immunocompromised mice. The potent activity of these newly identified compounds, UM171 being the prototype, is independent of suppression of the aryl hydrocarbon receptor, which targets cells with more-limited regenerative potential. The properties of UM171 make it a potential candidate for hematopoietic stem cell transplantation and gene therapy.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25237102 PMCID: PMC4372335 DOI: 10.1126/science.1256337
Source DB: PubMed Journal: Science ISSN: 0036-8075 Impact factor: 47.728